Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases.

Xu, Ziyang; Patel, Ami; Tursi, Nicholas J; Zhu, Xizhou; Muthumani, Kar; Kulp, Daniel W; Weiner, David B

Xu, Ziyang; Patel, Ami; Tursi, Nicholas J; Zhu, Xizhou; Muthumani, Kar; Kulp, Daniel W; Weiner, David B.

Afiliación

Xu Z; The Vaccine and Immunotherapy Center, Wistar Institute, Philadelphia, PA, United States.
Patel A; Department of Pharmacology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Tursi NJ; The Vaccine and Immunotherapy Center, Wistar Institute, Philadelphia, PA, United States.
Zhu X; The Vaccine and Immunotherapy Center, Wistar Institute, Philadelphia, PA, United States.
Muthumani K; The Vaccine and Immunotherapy Center, Wistar Institute, Philadelphia, PA, United States.
Kulp DW; The Vaccine and Immunotherapy Center, Wistar Institute, Philadelphia, PA, United States.
Weiner DB; The Vaccine and Immunotherapy Center, Wistar Institute, Philadelphia, PA, United States.

Front Med Technol ; 2: 571030, 2020.

Article en En | MEDLINE | ID: mdl-35047878

Palabras clave

COVID-19; DNA vaccines; DNA-launched nanoparticle vaccines; SARS-CoV-2; coronaviruses; emerging infectious diseases (EIDs); intradermal electroporation; intranasal vaccines

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Med Technol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google